Utilize the data and tweets at hand to foresee if the closing price of $bmy will elevate or diminish at 2017-04-11. Only answer with Rise or Fall.
Context: date,open,high,low,close,adj-close,inc-5,inc-10,inc-15,inc-20,inc-25,inc-30
2017-03-28,-0.3,0.3,-0.5,0.3,0.3,-0.3,0.3,0.9,1.0,0.8,0.1
2017-03-29,0.4,1.1,-0.0,-0.4,-0.4,0.0,0.4,1.2,1.3,1.3,0.7
2017-03-30,1.1,1.2,-0.2,-1.1,-1.1,1.0,1.2,2.0,2.3,2.3,1.8
2017-03-31,1.7,2.4,-0.4,-1.8,-1.8,2.2,2.6,3.3,3.9,4.0,3.7
2017-04-03,0.6,1.8,-0.6,-0.3,-0.3,1.9,2.5,3.3,3.9,4.2,4.0
2017-04-04,0.1,0.4,-0.4,-0.1,-0.1,1.2,2.4,3.1,3.9,4.1,4.1
2017-04-05,1.7,2.0,-0.2,-2.0,-1.2,1.6,3.1,3.9,4.8,5.2,5.3
2017-04-06,-0.5,0.5,-1.5,0.4,0.4,0.6,2.3,3.1,4.0,4.5,4.7
2017-04-07,-0.3,0.4,-1.0,0.2,0.2,0.1,1.7,2.5,3.4,4.0,4.3
2017-04-10,0.0,0.7,-0.3,-0.1,-0.1,0.1,1.4,2.3,3.2,3.9,4.3

2017-03-28: rt AT_USER benzinga's option alert recap from march 28  $afsi $alrm $amat $spls $mycc $bmy $kite $casy $res $five|$bmy is in scoop pattern winning 85.71% in the past. |benzinga: benzinga's option aler
2017-03-29: bristol-myers squibb co $bmy director lamberto andreotti sells 34,000 shares |bristol-myers squibb co $bmy director lamberto andreotti sells 34,000 shares |bristol-myers squibb co $bmy director lamber
2017-03-30: #bristolmyerssquibb bristol-myers squibb co director lamberto andreotti sells 34,000 shares. read more:  $bmy|#bristolmyerssquibb bristol-myers squibb co director lamberto andreotti sells 34,000 share
2017-03-31: our $bmy smarttrack found : AT_USER carnivalesque by neil jordan is now available for pre-order!     #markets | members have an advantage. see track record &amp; join  $bmy $pot $apa $cnq $ccl $ba|#br
2017-04-01: rt AT_USER  alerted another winner. must see track record &amp; subscribe  $jah $clr $d¡­|rt AT_USER $bmy before the weekend. selling put 50 for may. seems abit over sold and ~47 is support. high prob
2017-04-02: stocks going ex-dividend the first week of april  $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $gps $intu $jpm|stocks going ex-dividend the first week of april $axp $bks $bmy $cmcsa $csco $dgx $gd $gis $
2017-04-03: rt AT_USER survival from checkmate-067 (opdivo+yervoy in melanoma), via james larkin $bmy #aacr17 |earlybird twitter approved for trade floors. $bmy gay talese, author of high notes, was interviewed o
2017-04-04: rt AT_USER AT_USER adam please look into $bmy collaboration with AT_USER and $nwbo trial starts 4/17 |$bmy bmo capital reiterates market perform rating, $45 pt |bristol-myers squibb co $bmy rating rei
2017-04-05: rt AT_USER get ready for an explosive run $vdrm the next $owcp $cnbx $usrm $axim $cara $zyne $gwph $pfe $mrk $bmy #tradeideas htt¡­|rt AT_USER pepsi's ceo just had to go there! $vrx $agn $myl $mrk $jn
2017-04-06:  members have an advantage. see track record &amp; join  $bmy $pot $apa $cnq $ccl $ba|rt AT_USER how uncoupling opdivo and yervoy could favour keytruda, via AT_USER  #aacr17 $bmy $mrk|$bmy is in stoch
2017-04-07: rt AT_USER is now a good time to buy $jpm $esrx $bac $ibm $mpc  $teva $bmy $abbv $hot $v $mdt $axp $dow #ces2¡­|rt AT_USER does anyone else feel that the anti-ctla4 class is essentially useless, with 
2017-04-08: bristol-myers squibb $bmy receiving somewhat favorable news coverage, report shows |bristol-myers squibb $bmy receiving somewhat favorable news coverage, report shows |bristol-myers squibb $bmy receiv
2017-04-09: rt AT_USER $vdrm #fda approval n about 6-8 weeks #tradeideas #viagra #cialis $owcp $cnbx $usrm $pre $mrk $bmy #stocks #cannabis h¡­|$vdrm #fda approval n about 6-8 weeks #tradeideas #viagra #cialis $o
2017-04-10: rt AT_USER insider trading activity bristol-myers squibb co (nyse:bmy) ¨c director sold 34,000 shares of stock |insider selling: bristol-myers squibb co $bmy director sells 34,000 shares of stock |ins
Answer:
Fall